J-Pharma Co Ltd (520A) Stock Price & News

All values in JPY	Jun 2026
Revenue	-
Cost of goods sold	-
Cost of revenue	-
Research and development expenses	487.59M
Total research and development expenses	-
Selling, general, and admin expenses	82.71M
Operating expense	570.30M
Total operating expenses	570.30M
Operating income	-570.30M
Other non operating income	40.00K
EBT including unusual items	-561.30M
EBT excluding unusual items	-564.55M
Income tax expense	237.00K
Effective tax rate	-0.04%
Other operating expenses	-
Net income	-561.54M
Net profit margin	-
Earnings per share	-
Interest and investment income	5.90M
Interest expense	-
Net interest expenses	5.90M
Depreciation and amortization charges	-
EBITDA	-570.00M
Gain or loss from assets sale	-

Finance